Bluejay Diagnostics (BJDX) — Bank of America Entities Drop Below 10% (End Section 16)

What Happened Bank of America Corporation, Bank of America, N.A. (BANA), and BofA Securities, Inc. (BOFAS) jointly filed a Form 4 to state they are no longer subject to Section 16 reporting for Bluejay Diagnostics (BJDX) because their beneficial ownership has decreased below 10%. The filing does not list a specific purchase or sale, nor does it provide share counts or dollar values in this notice — it simply notifies a change in reporting status.

Key Details

• Filing date: 2026-07-22; Period of report: 2026-07-21.
• Filers: Bank of America Corporation, Bank of America, N.A., and BofA Securities, Inc. (joint filing).
• Reason: Beneficial ownership fell below the 10% threshold, ending their Section 16 reporting obligation.
• Shares owned after transaction: Not specified in this filing — only that ownership is now below 10%.
• Notable footnote: Joint statement by the three entities clarifying the change in Section 16 status.
• Timeliness: Filed on 2026-07-22 for the 2026-07-21 reporting period (no late‑filing indication in the provided remarks).

Context This is an institutional reporting update, not a disclosed insider sale or purchase in this document. Dropping below 10% simply ends the filers’ obligation to report under Section 16 going forward — it does not necessarily mean they sold shares (could result from prior dispositions, dilution, or other changes). Retail investors wanting details on any actual trades should review earlier or related Form 4/Form 13 filings for specific transactions.